Clinical Trial Update: A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on finerenone for chronic kidney disease in people with Type 1 diabetes, focusing on effectiveness and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 1 Diabetes Mellitus

Drugs mentioned

• Finerenone (finerenone)

Snippet

Sponsor: Bayer | Conditions: Chronic Kidney Disease, Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED